146 related articles for article (PubMed ID: 26110507)
1. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
Bunger JC; Melton-Celsa AR; Maynard EL; O'Brien AD
Toxins (Basel); 2015 Jun; 7(6):2306-20. PubMed ID: 26110507
[TBL] [Abstract][Full Text] [Related]
2. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
[TBL] [Abstract][Full Text] [Related]
3. Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer.
Melton-Celsa AR; Kokai-Kun JF; O'Brien AD
Mol Microbiol; 2002 Jan; 43(1):207-15. PubMed ID: 11849548
[TBL] [Abstract][Full Text] [Related]
4. Stx2 subtyping of Shiga toxin-producing Escherichia coli isolated from cattle in France: detection of a new Stx2 subtype and correlation with additional virulence factors.
Bertin Y; Boukhors K; Pradel N; Livrelli V; Martin C
J Clin Microbiol; 2001 Sep; 39(9):3060-5. PubMed ID: 11526129
[TBL] [Abstract][Full Text] [Related]
5. Virulence Potential of Activatable Shiga Toxin 2d-Producing Escherichia coli Isolates from Fresh Produce.
Melton-Celsa AR; O'Brien AD; Feng PC
J Food Prot; 2015 Nov; 78(11):2085-8. PubMed ID: 26555533
[TBL] [Abstract][Full Text] [Related]
6. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
Pellino CA; Karve SS; Pradhan S; Weiss AA
J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
[TBL] [Abstract][Full Text] [Related]
7. Activatable Shiga toxin 2d (Stx2d) in STEC strains isolated from cattle and sheep at slaughter.
Tasara T; Bielaszewska M; Nitzsche S; Karch H; Zweifel C; Stephan R
Vet Microbiol; 2008 Sep; 131(1-2):199-204. PubMed ID: 18417300
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
Friedrich AW; Bielaszewska M; Zhang WL; Pulz M; Kuczius T; Ammon A; Karch H
J Infect Dis; 2002 Jan; 185(1):74-84. PubMed ID: 11756984
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR assays to detect 10 Shiga toxin subtype (Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g) genes.
Harada T; Wakabayashi Y; Seto K; Lee K; Iyoda S; Kawatsu K
Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115874. PubMed ID: 36529020
[TBL] [Abstract][Full Text] [Related]
10. Relationship between stx genotype and Stx2 expression level in Shiga toxin-producing Escherichia coli O157 strains.
Kawano K; Ono H; Iwashita O; Kurogi M; Haga T; Maeda K; Goto Y
Jpn J Infect Dis; 2012 Jul; 65(4):322-5. PubMed ID: 22814156
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin subtypes display dramatic differences in potency.
Fuller CA; Pellino CA; Flagler MJ; Strasser JE; Weiss AA
Infect Immun; 2011 Mar; 79(3):1329-37. PubMed ID: 21199911
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity.
Russo LM; Melton-Celsa AR; Smith MJ; O'Brien AD
PLoS One; 2014; 9(3):e93463. PubMed ID: 24671194
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli.
Zhang W; Bielaszewska M; Friedrich AW; Kuczius T; Karch H
Appl Environ Microbiol; 2005 Jan; 71(1):558-61. PubMed ID: 15640236
[TBL] [Abstract][Full Text] [Related]
14. Development of a homogeneous time-resolved FRET (HTRF) assay for the quantification of Shiga toxin 2 produced by
Nakamura K; Tokuda C; Arimitsu H; Etoh Y; Hamasaki M; Deguchi Y; Taniguchi I; Gotoh Y; Ogura Y; Hayashi T
PeerJ; 2021; 9():e11871. PubMed ID: 34395095
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
[TBL] [Abstract][Full Text] [Related]
16. A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli.
He X; Quiñones B; McMahon S; Mandrell RE
Toxins (Basel); 2012 Jul; 4(7):487-504. PubMed ID: 22852065
[TBL] [Abstract][Full Text] [Related]
17. Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.
Mitsui T; Watanabe-Takahashi M; Shimizu E; Zhang B; Funamoto S; Yamasaki S; Nishikawa K
Infect Immun; 2016 Sep; 84(9):2653-61. PubMed ID: 27382021
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources.
Beutin L; Steinrück H; Krause G; Steege K; Haby S; Hultsch G; Appel B
J Appl Microbiol; 2007 Mar; 102(3):630-9. PubMed ID: 17309611
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxin 2 subtypes of enterohemorrhagic E. coli O157:H- E32511 analyzed by RT-qPCR and top-down proteomics using MALDI-TOF-TOF-MS.
Fagerquist CK; Zaragoza WJ
J Am Soc Mass Spectrom; 2015 May; 26(5):788-99. PubMed ID: 25667061
[TBL] [Abstract][Full Text] [Related]
20. Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.
Kulkarni AA; Fuller C; Korman H; Weiss AA; Iyer SS
Bioconjug Chem; 2010 Aug; 21(8):1486-93. PubMed ID: 20669970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
